http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Two studies suggest that two peptide agents used either together or individually with a low-dose of a standard chemotherapy drug might offer more effective cancer therapy than current standard single-drug treatments. http://medicalxpress.com/news/2012-08-combination-peptide-therapies-effective-toxic.html Cancer Thu, 16 Aug 2012 15:57:31 EST news264351364 Investigators at the University of Texas MD Anderson Cancer Center, Houston, have reported on a new approach to treating previously inoperable complex pancreatic adenocarcinoma that has significantly increased long-term survival for some patients. Pancreatic adenocarcinoma is one of the most devastating forms of pancreatic cancer with survival rates of only 5 percent at five years. Surgical removal of these tumors offers a chance for cure, but it is estimated that only about 20 percent of patients can undergo this treatment. The tumor in the pancreas often grows into adjacent vital blood vessels, and this is the most common reason a surgeon will consider pancreatic cancer to be inoperable and incurable. However, the MD Anderson investigators have achieved an important milestone in the surgical treatment of the disease in terms of improving prognosis for patients who meet the criteria for a newly developed protocol. http://medicalxpress.com/news/2012-06-treatment-protocol-survival-cases-inoperable.html Surgery Wed, 27 Jun 2012 00:00:01 EST news259948199 Combining the investigational agents REGN910 and aflibercept yielded statistically significant improvements in antitumor effects in animal models compared with either agent alone, according to results presented at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics, held Nov. 12-16, 2011. http://medicalxpress.com/news/2011-11-combination-therapy-potent-tumor-growth.html Cancer Sun, 13 Nov 2011 14:14:57 EST news240416091